Reliagene Technologies Overview

  • Year Founded
  • 1990

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Reliagene Technologies General Information

Description

Provider of DNA testing services in courts. The company provides polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP), mitochondrial DNA sequencing (mtDNA), and Y- chromosome DNA testing (Y-STR).

Contact Information

Website
www.reliagene.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 5525 Mounes Street
  • Suite 101
  • New Orleans, LA 70123
  • United States
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Orchid Cellmark(Laboratory Services)
Vertical(s)
Life Sciences
Corporate Office
  • 5525 Mounes Street
  • Suite 101
  • New Orleans, LA 70123
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reliagene Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Reliagene Technologies‘s full profile, request access.

Request a free trial

Reliagene Technologies Patents

  • 14

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • Pending

  • Expiring in next 12 mo

Reliagene Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080206755-A1 First primer for both a filled site containing an interspersed element and an empty site which does not contain the interspersed element, a second primer for the filled site, and a third primer for the empty site; to test any type of interspersed genetic element containing direct repeat sequences Active 23-Feb-2007
US-7794983-B2 First primer for both a filled site containing an interspersed element and an empty site which does not contain the interspersed element, a second primer for the filled site, and a third primer for the empty site; to test any type of interspersed genetic element containing direct repeat sequences Active 23-Feb-2007
US-20070003944-A1 Inference of human geographic origins using alu insertion polymorphisms Inactive 14-Dec-2004
US-20060141512-A1 Novel method for separation of human sperm from biological samples for application in human identification Inactive 03-Dec-2004
US-20060099620-A1 Polymerase chain reaction for amplifying dna containing a human/chimp mismatch using primers of given sequence Active 08-Oct-2004 C12Q1/6879
To view Reliagene Technologies’s complete patent history, request access »

Reliagene Technologies FAQs

  • When was Reliagene Technologies founded?

    Reliagene Technologies was founded in 1990.

  • Where is Reliagene Technologies headquartered?

    Reliagene Technologies is headquartered in New Orleans, LA.

  • What industry is Reliagene Technologies in?

    Reliagene Technologies’s primary industry is Laboratory Services (Healthcare).

  • Is Reliagene Technologies a private or public company?

    Reliagene Technologies is a Private company.

  • What is the current valuation of Reliagene Technologies?

    The current valuation of Reliagene Technologies is .

  • What is Reliagene Technologies’s current revenue?

    The current revenue for Reliagene Technologies is .

  • When was Reliagene Technologies acquired?

    Reliagene Technologies was acquired on 31-Oct-2007.

  • Who acquired Reliagene Technologies?

    Reliagene Technologies was acquired by Orchid Cellmark(Laboratory Services).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »